CELU

Celularity Inc. Class A Common Stock
Data: 2026-02-02
$1.26
Price
2.46%
Change
$4.35
52W High
$1.0007
52W Low

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Quick Stats
Feb 02, 2026

52.7

AI Score

HOLD

0.29

Volume Ratio

Dec 05, 2025

Next Earnings

15

+ve Days (30d)

15

-ve Days (30d)

CELU Stock Summary

Last updated Feb 02, 2026

CELU is currently trading at $1.26, positioned below its 200-day moving average of $2.08, suggesting bearish momentum. The stock has a 52-week range of $1.0007 to $4.35.

Technical Analysis: The 50-day moving average stands at $1.48, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 42.754, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.259, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates CELU at 52.7/100 with a HOLD recommendation.

CELU (Celularity Inc. Class A Common Stock) Indicators

Last updated Feb 02, 2026

Indicator Value
RSI(14) 42.754
CMF (20) 0.259
ROC (10) -3.817
ADX (14) 11.394
Indicator Value
MACD (12,26,9) -0.046
AROONOSC (14) -57.143
WILLAMS %R (14) -61.111
MFI (14) 45.08
CELU Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

CELU Price vs Max Options Open Interest
CELU Max Change In Options Open Interest

CELU Options - Sort by Max open Interest (near term)

3rd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CELU Daily Out of Money Options - Sort by Max open Interest (near term)

3rd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CELU Daily In the Money Options - Sort by Max open Interest (near term)

3rd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CELU Most Active Options by Volume(near term)

3rd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Celularity Inc. Class A Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

CELU Moving Averages Analysis

CELU (Celularity Inc. Class A Common Stock) Simple Moving Averages

Moving Averages are last updated Feb 02, 2026

Days MA
10 1.27
20 1.28
30 1.28
50 1.48
100 1.74
200 2.08

CELU Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 35.2 million
Earnings/Share ($) -3.33
Net Proft Margin (%) -1.9875
Dividend/Share ($) --
EPS Estimate Current Year ($) 0
EPS Estimate Next Year ($) 0
WallStreet Target Price ($) 2.5
Most Recent Quarter